These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3716883)

  • 1. Myotonic dystrophy treated with selenium and vitamin E.
    Orndahl G; Selldén U; Hallin S; Wetterqvist H; Rindby A; Selin E
    Acta Med Scand; 1986; 219(4):407-14. PubMed ID: 3716883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study.
    Orndahl G; Grimby G; Grimby A; Johansson G; Wilhelmsen L
    J Intern Med; 1994 Mar; 235(3):205-10. PubMed ID: 8120515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium selenite and vitamin E treatment in myotonic dystrophy.
    Bäckman E; Henriksson KG
    J Intern Med; 1990 Dec; 228(6):577-81. PubMed ID: 2177768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium therapy of myotonic dystrophy.
    Orndahl G; Rindby A; Selin E
    Acta Med Scand; 1983; 213(3):237-9. PubMed ID: 6846068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.
    Torres C; Moxley RT; Griggs RC
    J Neurol Sci; 1983 Jul; 60(1):157-68. PubMed ID: 6875612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of selenium and vitamin E in boys with muscular dystrophy.
    Gamstorp I; Gustavson KH; Hellström O; Nordgren B
    J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
    Airenne AL; Westermarck T
    Med Biol; 1984; 62(2):154. PubMed ID: 6471936
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of extracellular calcium in the pathophysiology of myotonic dystrophy.
    Oz L; Dinc ME; Oz ME; Frank GB
    Med Hypotheses; 1993 Oct; 41(4):370-4. PubMed ID: 8289707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selenium and vitamin E on muscular strength and blood parameters in Steinert disease.
    Rossi B; Siciliano G; Risaliti R; Muratorio A
    Ital J Neurol Sci; 1990 Feb; 11(1):37-42. PubMed ID: 2332324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine in the treatment of myotonia in myotonic dystrophy.
    Grant R; Sutton DL; Behan PO; Ballantyne JP
    J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):199-206. PubMed ID: 3553433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitamin E and selenium-containing preparations in the prevention treatment of tetracycline-induced lesions of the liver].
    Skakun NP; Vysotskiĭ IIu
    Antibiotiki; 1983 Aug; 28(8):608-12. PubMed ID: 6638974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal physical profile assessment of skeletal muscle manifestations in myotonic dystrophy.
    Nitz JC; Burns YR; Jackson RV
    Clin Rehabil; 1999 Feb; 13(1):64-73. PubMed ID: 10327099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dantrolene sodium in myotonic dystrophy.
    Mamoli B; Dal-Bianco P; Zeitlhofer K
    Eur Neurol; 1983; 22(1):29-34. PubMed ID: 6840139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions.
    Ip C; White G
    Carcinogenesis; 1987 Dec; 8(12):1763-6. PubMed ID: 3119243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of injectable vitamin E and selenium-vitamin E emulsion in ewes and suckling lambs to prevent nutritional muscular dystrophy.
    Norton SA; McCarthy FD
    J Anim Sci; 1986 Feb; 62(2):497-508. PubMed ID: 3957817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
    Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
    Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of testosterone in myotonic dystrophy.
    Griggs RC; Pandya S; Florence JM; Brooke MH; Kingston W; Miller JP; Chutkow J; Herr BE; Moxley RT
    Neurology; 1989 Feb; 39(2 Pt 1):219-22. PubMed ID: 2521699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selenium and vitamin E on incidence of retained placenta.
    Eger S; Drori D; Kadoori I; Miller N; Schindler H
    J Dairy Sci; 1985 Aug; 68(8):2119-22. PubMed ID: 4044976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophy: relative sensitivity of symptoms signs and abnormal investigations.
    Avaria M; Patterson V
    Ulster Med J; 1994 Oct; 63(2):151-4. PubMed ID: 8650827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1.
    Bachasson D; Moraux A; Ollivier G; Decostre V; Ledoux I; Gidaro T; Servais L; Behin A; Stojkovic T; Hébert LJ; Puymirat J; Eymard B; Bassez G; Hogrel JY
    Neuromuscul Disord; 2016 Jul; 26(7):428-35. PubMed ID: 27234310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.